Accounts receivable, net (including changes in related party balances of (240) and 5,878 during the nine months ended march 31, 2026 and 2025, respectively)
-2,582,997
8,471,584
321,244
-438,559
Inventories
580,741
5,001,809
1,087,010
813,503
Prepaid expenses and other assets (including changes in related party balances of (15,028) and (2,782) during the nine months ended march 31, 2026 and 2025, respectively)
322,883
192,942
-134,087
-55,249
Accounts payable (including changes in related party balances of 4,300 and (49,991) during the nine months ended march 31, 2026 and 2025, respectively)
-10,059,838
12,465,867
901
630,722
Accrued liabilities (including changes in related party balances of 286 and 571 during the nine months ended march 31, 2026 and 2025, respectively)
272,577
219,689
-259,350
219,690
Income taxes payable
-79,617
63,063
4,978
26,678
Deferred revenue
832,889
274,751
296,622
65,585
Other long-term liabilities (including changes in related party balances of (114) and 729 during the nine months ended march 31, 2026 and 2025, respectively)
11,660
5,362
3,171
-2,500
Net cash (used in) provided by operating activities
-6,615,426
-23,898
-917,523
863,613
Purchases of property, plant, and equipment (including payments to related parties of 9,366 and 10,508 during the nine months ended march 31, 2026 and 2025, respectively)
80,278
21,221
32,270
22,678
Investment in equity securities
17,000
25,000
-
56,000
Acquisition, net of cash acquired
-
-
-
0
Net cash used in investing activities
-97,278
-46,221
-32,270
-78,678
Proceeds from lines of credit and term loans
3,996,465
210,212
28,588
81,214
Repayment of lines of credit and term loans
101,677
111,851
11,540
194,591
Payment of debt issuance costs
13,698
9,785
-
-
Proceeds from exercise of stock options
5,422
5,003
7,922
14,029
Payment for withholding taxes related to settlement of equity awards
31,325
27,424
43,642
65,421
Stock repurchases
-
-
-
200,000
Issuances of common stock in public offerings, net of issuance costs of 42,575
-
-
-
0
Debt issuance costs in connection with amended 2029 convertibles notes
0
-
-
31,217
Proceeds from issuance of convertible notes, net of issuance costs-Convertible Senior Notes Due2029
-
-
-
0
Proceeds from issuance of 2028 convertible notes, net of issuance costs of 16,304
0
-
-
683,696
Proceeds from issuance of convertible notes, net of issuance costs-Convertible Senior Notes Due2030
-
-
-
2,255,973
Purchase of capped calls
-
-
-
182,215
Proceeds related to receivables purchase agreement, net
4,191
-
-
-
Other
-40
7
7
11
Net cash provided by financing activities
3,859,338
66,162
-18,665
1,849,427
Effect of exchange rate fluctuations on cash
-393
-1,573
-4,588
847
Net (decrease) increase in cash, cash equivalents and restricted cash
-2,853,759
-5,530
-973,046
2,635,209
Cash, cash equivalents and restricted cash at the beginning of the period
4,199,255
4,199,255
5,172,301
2,089,231
Cash, cash equivalents and restricted cash at the end of the period
1,339,966
4,193,725
4,199,255
5,172,301
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.